AAA

Actuate Therapeutics, Inc.

No trades
See on Supercharts

ACTU fundamentals

An in-depth look to Actuate Therapeutics, Inc. operating, investing, and financing activities

ACTU free cash flow for Q2 24 is -2.72 M USD. For 2023, ACTU free cash flow was -21.63 M USD and operating cash flow was -21.63 M USD.

Q1 '23
Q2 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth